COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01397227
Recruitment Status : Completed
First Posted : July 19, 2011
Last Update Posted : September 7, 2012
The PATH Malaria Vaccine Initiative (MVI)
Seattle Children’s Research Institute (SCRI)
Information provided by (Responsible Party):
Crucell Holland BV

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2012
Actual Study Completion Date : May 2012
Certification/Extension First Submitted : September 3, 2012